Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma (Q65465469)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma |
clinical trial |
Statements
An Open Label Phase I of Oral Nintedanib Plus Weekly Docetaxel Therapy in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma After Failure of Platinum -Based First Line Chemotherapy (English)
0 references
7 March 2016
0 references
11 October 2019
0 references
14
0 references
18 year
0 references